ResultsIQ

ResultsIQ › Latest results › Venky's (India) Limited

Venky's (India) Limited Q2 FY26 earnings call summary

NSE: VENKEYS · BSE: 523261

Earnings call of 10 Nov 2025, summarised by AI from the filing.

Poultry prices started moving positively in last week of October and are now above production cost.

Key takeaways

  1. Price recovery Poultry prices started moving positively in last week of October and are now above production cost.
  2. AHP growth Animal Health Products revenue expected to cross ₹370-380 cr this year from ₹335 cr last year.
  3. Raw material Maize and soya prices trading below MSP, limiting margin improvement in oilseed segment.

Original filing on BSE

Venky's (India) Limited Q1 FY27 results

As filed: Revenue ₹1,118 cr (+29% year on year), EBITDA ₹69.2 cr (+201% year on year), PAT ₹50.0 cr (+212% year on year), EBITDA margin 6.2% (+353 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹1,100 cr (+31% year on year), EBITDA ₹130 cr (+300% year on year), PAT ₹96.7 cr (+300% year on year), EBITDA margin 11.8% (+883 bps). Score 97 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 883 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −18.5% in 29 days (Nifty 500: +1.0%).
  • Q3 FY26: Revenue ₹960 cr (+9% year on year), EBITDA ₹69.9 cr (+141% year on year), PAT ₹48.6 cr (+143% year on year), EBITDA margin 7.3% (+399 bps). Score 76 of 100, Above trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were above it. EBITDA margin rose 399 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −19.2% in 30 days (Nifty 500: −5.9%).
  • Q2 FY26: Revenue ₹801 cr (+3% year on year), EBITDA −₹31.0 cr (−300% year on year), PAT −₹27.0 cr (−300% year on year), EBITDA margin -3.9% (−568 bps). Score 20 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 568 bps year on year. Revenue fell 8% from last quarter. Share price after the results: −12.4% in 28 days (Nifty 500: +1.4%).
  • Q1 FY26: Revenue ₹866 cr (+7% year on year), EBITDA ₹23.0 cr (−78% year on year), PAT ₹16.0 cr (−79% year on year), EBITDA margin 2.7% (−1,000 bps). Score 46 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 1000 bps year on year. Other income 55% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +0.3% in 28 days (Nifty 500: +0.6%).
  • Q4 FY25: Revenue ₹843 cr (−6% year on year), EBITDA ₹25.0 cr (−49% year on year), PAT ₹12.0 cr (−65% year on year), EBITDA margin 3.0% (−250 bps). Score 20 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 250 bps year on year. Other income 52% of PBT. Tax rate 43%. Revenue fell 4% from last quarter. Share price after the results: −1.1% in 30 days (Nifty 500: +7.7%).
  • Q3 FY25: Revenue ₹882 cr (−7% year on year), EBITDA ₹29.0 cr, PAT ₹20.0 cr, EBITDA margin 3.3% (+392 bps). Score 23 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin rose 392 bps year on year. Other income 43% of PBT.
  • Q2 FY25: Revenue ₹774 cr (−15% year on year), EBITDA ₹14.0 cr (−73% year on year), PAT ₹8.0 cr (−76% year on year), EBITDA margin 1.8% (−378 bps). Score 0 of 100, Below trend. EBITDA margin fell 378 bps year on year. Other income 91% of PBT. Not enough history for a trend yet: scored on growth alone. Revenue fell 4% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Venky's (India) Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.